MORROW et al., 1989 - Google Patents
Long-term observation of baboons, rhesus monkeys, and chimpanzees inoculated with HIV and given periodic immunosuppressive treatmentMORROW et al., 1989
- Document ID
- 5423305545068493138
- Author
- MORROW W
- HOMSY J
- EICHBERG J
- KROWKA J
- PAN L
- GASTON I
- LEGG H
- LERCHE N
- THOMAS J
- LEVY J
- Publication year
- Publication venue
- AIDS research and human retroviruses
External Links
Snippet
Baboons, rhesus monkeys, and chimpanzees were injected with the human immunodeficiency virus (HIV) and monitored for up to 4 years. Various immunosuppressive regimens were used during this time in attempts to induce development of the acquired …
- 241000282579 Pan 0 title abstract description 35
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fultz et al. | Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome | |
| Nara et al. | Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses | |
| Hu et al. | Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees | |
| MORROW et al. | Long-term observation of baboons, rhesus monkeys, and chimpanzees inoculated with HIV and given periodic immunosuppressive treatment | |
| Levy et al. | Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS | |
| Marthas et al. | Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV | |
| Novembre et al. | Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1 | |
| Blattner et al. | HIV causes aids | |
| Issel et al. | Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus | |
| Miyoshi et al. | Natural infection in non‐human primates with adult T‐cell leukemia virus or a closely related agent | |
| Krowka et al. | Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. | |
| Fultz et al. | Superinfection of a chimpanzee with a second strain of human immunodeficiency virus | |
| Putkonen et al. | Experimental infection of cynomolgus monkeys (Macaca fascicularis) with HIV-2 | |
| Khabbaz et al. | Simian immunodeficiency virus needlestick accident in a laboratory worker | |
| Eichberg et al. | T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees | |
| Melief et al. | Transmission of lymphotropic retroviruses (HTLV-I and LAV/HTLV-III) by blood transfusion and blood products | |
| Castro et al. | Persistent infection of baboons and rhesus monkeys with different strains of HIV-2 | |
| EP0554389B2 (en) | Molecular clones of hiv-1 and uses thereof | |
| Jenkins et al. | Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus–infected cells by leukocytes from human neonates and adults | |
| Murphy et al. | HTLV‐I‐associated leukemia: a model for chronic retroviral diseases | |
| Pepose et al. | Serologic markers after the transplantation of corneas from donors infected with human immunodeficiency virus | |
| Fultz et al. | Prolonged CD4+ lymphocytopenia and thrombocytopenia in a chimpanzee persistently infected with human immunodeficiency virus type 1 | |
| Fenyö et al. | Broad cross-neutralizing activity in serum is associated with slow progression and low risk of transmission in primate lentivirus infections | |
| Gorse et al. | Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration | |
| Joag et al. | Early activation of PBMC and appearance of antiviral CD8+ cells influence the prognosis of SIV‐induced disease in rhesus macaques |